Delivery Order SPE2DB22D3010-SPE2DB24FP1BJ
- Not listed
- This federal contract award, valued at $1,064.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Carvedilol ER 80 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of February 3, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $27,914.71 firm fixed-price delivery order is for the provision of Carvedilol ER 80 mg capsules, a cardiovascular medication. The contract has an ultimate completion date of January 11, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $17,903.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of Carvedilol ER 20 mg capsules. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of...
- This federal contract award, valued at $10,667.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,561,853,439 units of the medication Carvedilol ER 40 mg capsules, with an ultimate completion date of August 18, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,418.57 firm fixed-price delivery order is for the supply of Carvedilol ER 20 mg capsules. The award is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc. valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,146.16 firm fixed-price delivery order is for the supply of Carvedilol ER 20 mg capsules. The award has a performance period ending on February 12, 2024. The contract was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $6,684.08, is for the delivery of Carvedilol ER 20 mg capsules. The award is a firm fixed-price delivery order with a completion date of January 16, 2024. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,320.90 firm-fixed-price delivery order is for the supply of Carvedilol ER 10 mg capsules, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the...
- This federal contract award, valued at $2,283.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 10 mg capsules. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as Amerisourcebergen, with a ceiling value of up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,481.16 firm fixed-price delivery order is for the supply of Carvedilol ER 80 mg capsules to support military and government healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB24FP1BJDelivery Order
This federal contract award, valued at $5,177.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order for the pharmaceutical product Carvedilol ER 80 mg Capsule 30s, with a performance period ending on December 6, 2023. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 12/5/23 |